Author

Katrina Sandy

Institution: Bristol-Myers Squibb (United States)

Observed institutions: Bristol-Myers Squibb (United States), The Princeton Festival

OpenAlex ID: A5113798597

Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C

2012 · Claudio Pasquinelli, Fiona McPhee, et al. · Antimicrobial Agents and Chemotherapy · 51

A Phase I Dose Escalation Study of KW-2449, an Oral Multi-Kinase Inhibitor Against FLT3, Abl, FGFR1 and Aurora in Patients with Relapsed/Refractory AML, Treatment Resistant/Intolerant CML, ALL and MDS.

2007 · Jorge Cortes, Gail J. Roboz, et al. · Blood · 13

Works count: 2

Citation count: 64

H-index: 2

I10-index: 2